Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Pediatr.

Sec. Pediatric Critical Care

This article is part of the Research TopicAdvancing pediatric critical care: Sepsis, immune dysregulation, and precision therapiesView all 13 articles

Burden and Outcomes of Pediatric ARDS Among Children with Sepsis: A Cohort Study

Provisionally accepted
Nawras  AsiriNawras Asiri1,2Lama  Khaled BahatheqLama Khaled Bahatheq1Naila  ShaheenNaila Shaheen3,4Yasser  M. KazzazYasser M. Kazzaz1,5,6*
  • 1Department of Pediatrics, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia
  • 2Department of Pediatrics, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia
  • 3Division of Biostatistics, Department of Population Health, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia
  • 4King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
  • 5King Abdullah International Medical Research Center, Riyadh, Saudi Arabia
  • 6College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia

The final, formatted version of the article will be published soon.

Objective: To determine the prevalence, clinical characteristics, outcomes, and mortality risk factors of pediatric acute respiratory distress syndrome (PARDS) among children with sepsis, and to compare pulmonary and extrapulmonary PARDS phenotypes. Methods: This retrospective cohort study analyzed children aged 0–14 years with Phoenix-defined sepsis admitted to a tertiary pediatric intensive care unit between 2015 and 2023. PARDS was defined according to PALICC-2 criteria. Demographics, illness severity, microbiology, organ support requirements, and clinical outcomes were compared between children with and without PARDS and between pulmonary and extrapulmonary phenotypes. Multivariable logistic regression models were used to identify independent predictors of mortality. Results: Among 279 children with Phoenix-defined sepsis, 161 (57.7%) developed PARDS. Children with PARDS were younger, had higher PELOD-2 and Phoenix severity scores, and required significantly more mechanical ventilation, vasoactive support, and renal replacement therapy compared with those without PARDS. Mortality was substantially higher in the PARDS cohort (36.6% vs. 7.6%). Model-estimated mortality probability increased stepwise with worsening PARDS severity and was highest among children with both septic shock and severe PARDS.. Pulmonary PARDS accounted for two-thirds of cases, whereas extrapulmonary PARDS demonstrated a higher inflammatory burden and more bacterial infections. In adjusted analyses, the presence of PARDS, higher PELOD-2 score, and greater cumulative fluid balance were independently associated with mortality. Conclusion: PARDS is a common and common complication associated with high risk of pediatric sepsis, associated with severe organ dysfunction, increased support requirements, and markedly elevated mortality. These findings underscore the need for multicenter validation to confirm the epidemiology and risk factors of sepsis-associated PARDS and to guide earlier recognition and management approaches for this high-risk population.

Keywords: Children, PALICC-2 definition, pediatric acute respiratory distress syndrome (PARDS), Phoenix Sepsis Score, Sepsis, septic shock

Received: 06 Dec 2025; Accepted: 30 Jan 2026.

Copyright: © 2026 Asiri, Bahatheq, Shaheen and Kazzaz. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Yasser M. Kazzaz

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.